What it is & primary uses
A potent acetylcholinesterase inhibitor isolated from Huperzia species.
Main benefits
- Some trials report cognitive-symptom improvement in clinical populations.
- Study quality, product purity and drug-like cholinergic effects prevent general nootropic use from being considered established.
Studied protocols
Research doses are grouped by outcome. They describe study designs—not a personal prescription.
100–400 mcg/day in clinical trials
- Study duration
- Commonly 4–12 weeks; protocol and outcome vary
- Interpretation
- Study quality, product purity and drug-like cholinergic effects prevent general nootropic use from being considered established.
Clinical or experimental context—professional guidance is especially appropriate.
04Food sources & equivalents＋
Can food provide a studied amount?
Huperzine A in this supplemental form does not have a reliable one-to-one food equivalent.
Dietary exposure; verify composition before comparing with a studied supplement dose
- How this was estimated
- Dose Radar compares the declared active ingredient with official composition data or the studied standardized extract—not with marketing names.
- Important limitation
- Natural content, preparation, bioavailability and formulation vary. This comparison does not prove equal physiological effect.
Food equivalents compare ingredient mass using published composition values. They do not prove equal absorption, formulation, physiological effect, safety or personal need.
Source: Huperzine A: current human evidence index ↗05How to take it for absorption & tolerance＋
With or without food
Human research has not established a universally superior fed or fasted protocol for this ingredient.
- Practical approach
- Once daily or divided; avoid casual stacking. Keep the formulation and daily total consistent with the evidence context shown above.
- Watch for
- Cholinesterase inhibitors
Meal guidance reflects human pharmacokinetic, clinical, official-label or evidence-review sources where available. A food pairing can change absorption or tolerability, but does not make a supplement necessary, effective or safe for every person.
Source: Huperzine A: current human evidence index ↗06Supplement interaction check＋
An unlisted pair means no established pair-specific interaction was identified in this review—not proof that every dose, product or person is safe.
This is not proof that every dose, product or user context is safe. Medication and condition checks still apply.
07Research notes＋
Limited evidence for the stated context. Study quality, product purity and drug-like cholinergic effects prevent general nootropic use from being considered established.
The displayed amount comes from human research or an official evidence summary. It is not a personalized prescription, and formulation can change whether the comparison is valid.
08Scientific references＋
Peer-reviewed human research and formal evidence reviews. Open each source to inspect the complete paper record.
09Expert & media references＋
Podcast and practitioner statements are clearly separated from research. They may explain practice or emerging ideas, but do not prove efficacy.
Dose Radar will leave this lane empty rather than invent or infer a professional opinion.